Puma Biotechnology (PBYI) Metrics: History & Chart

Puma Biotechnology, Inc.(PBYI)

Biotechnology · Los Angeles, CA

$9.50-0.17 (-1.76%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Puma Biotechnology, Inc.

Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administered neratinib (PB272), targets a range of indications. These include patients with early-stage HER2-overexpressed/amplified breast cancer, as well as adults suffering from advanced or metastatic HER2-positive breast cancer when used in combination with capecitabine. Furthermore, PB272 is being explored for solid tumors exhibiting HER2 mutations. The company holds a licensing agreement with Pfizer, Inc. for this drug and has established sub-licensing partnerships with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. Established in 2010, Puma Biotechnology maintains its headquarters in Los Angeles, California.

Los Angeles, CA

179 employees

www.pumabiotechnology.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Alan H. Auerbach

View full financials

Third-Party DCF Estimate (FMP)	$15.41
Price Gap vs Third-Party Estimate	+61.72%

7D Total Return	-1.53%
30D Total Return	+1.26%
YTD Total Return	+62.52%
1Y Total Return	+88.50%
3Y Total Return	+297.94%
5Y Total Return	+55.70%
10Y Total Return	-85.27%
15Y Total Return	N/A
20Y Total Return	N/A

2026	+62.52%
2025	+95.08%
2024	-29.56%
2023	+2.36%
2022	+39.14%
2021	-70.37%
2020

CAGR TTM	+87.93%
CAGR 3Y	+58.45%
CAGR 5Y	+9.26%
CAGR 10Y	-17.43%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	18.73
PE Ratio Avg TTM	12.02
PE Ratio Avg 3Y	9.92
Current VS TTM Avg	+55.87%
Current VS 3Y Avg	+88.78%
Current VS 5Y Avg	+49.56%

All Metrics

PBYI Valuation Metrics

PBYI Stock Price Metrics

PBYI Dividend Metrics

PBYI Growth Rate Metrics

PBYI Discounted Cash Flow Metrics

PBYI Returns By Period

PBYI Yearly Returns

PBYI Average Annual Returns By Period (CAGR)

PBYI Revenue Metrics

PBYI PE Ratio Metrics

PBYI PS Ratio Metrics

PBYI PB Ratio Metrics

PBYI Price to Free Cash Flow Ratio Metrics

PBYI Debt to Equity Ratio Metrics

PBYI PEG Ratio Metrics

PBYI FCF Yield

PBYI Earnings Yield

PBYI EBITDA Yield

PBYI OCF Yield

PBYI EV/EBIT Ratio Metrics

PBYI EV/EBITDA Ratio Metrics

PBYI EV/Assets Ratio Metrics

PBYI EV/Sales Ratio Metrics

PBYI Current Ratio Metrics

PBYI Quick Ratio Metrics

PBYI ROIC Metrics

PBYI Return on Assets Metrics

PBYI Return on Equity Metrics

PBYI Net Profit Margin Metrics

PBYI Gross Profit Margin Metrics

PBYI Tax Rate Metrics

PS Ratio	2.20
PS Ratio Avg TTM	1.60
PS Ratio Avg 3Y	1.05
Current VS TTM Avg	+37.20%
Current VS 3Y Avg	+108.56%
Current VS 5Y Avg	+168.97%

PB Ratio	3.67
PB Ratio Avg TTM	2.88
PB Ratio Avg 3Y	2.89
Current VS TTM Avg	+27.42%
Current VS 3Y Avg	+27.11%
Current VS 5Y Avg	-12.77%

PFCF Ratio	12.38
PFCF Ratio Avg TTM	7.91
PFCF Ratio Avg 3Y	6.30
Current VS TTM Avg	+56.44%
Current VS 3Y Avg	+96.55%
Current VS 5Y Avg	+61.60%

Debt/Equity Ratio	0.03
Debt/Equity Ratio Avg TTM	0.24
Debt/Equity Ratio Avg 3Y	1.29
Current VS TTM Avg	-85.56%
Current VS 3Y Avg	-97.30%
Current VS 5Y Avg	-98.50%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	8.08%
FCF Yield Avg TTM	13.01%
FCF Yield Avg 3Y	15.56%
Current VS TTM Avg	-37.91%
Current VS 3Y Avg	-48.06%
Current VS 5Y Avg	-43.85%

Earnings Yield	5.34%
Earnings Yield Avg TTM	9.76%
Earnings Yield Avg 3Y	11.41%
Current VS TTM Avg	-45.27%
Current VS 3Y Avg	-53.18%
Current VS 5Y Avg	-45.41%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	15.67
Ev/Ebit Ratio Avg TTM	10.51
Ev/Ebit Ratio Avg 3Y	8.11
Current VS TTM Avg	+49.07%
Current VS 3Y Avg	+93.15%
Current VS 5Y Avg	+96.25%

Ev/Ebitda Ratio	10.98
Ev/Ebitda Ratio Avg TTM	7.79
Ev/Ebitda Ratio Avg 3Y	5.90
Current VS TTM Avg	+40.95%
Current VS 3Y Avg	+86.17%
Current VS 5Y Avg	+92.34%

Ev/Assets Ratio	2.47
Ev/Assets Ratio Avg TTM	1.73
Ev/Assets Ratio Avg 3Y	1.20
Current VS TTM Avg	+42.53%
Current VS 3Y Avg	+105.59%
Current VS 5Y Avg	+138.94%

Ev/Sales Ratio	2.06
Ev/Sales Ratio Avg TTM	1.54
Ev/Sales Ratio Avg 3Y	1.09
Current VS TTM Avg	+33.87%
Current VS 3Y Avg	+88.39%
Current VS 5Y Avg	+116.10%

Current Ratio	2.91
Current Ratio Avg TTM	2.15
Current Ratio Avg 3Y	1.71
Current VS TTM Avg	+35.33%
Current VS 3Y Avg	+70.37%
Current VS 5Y Avg	+72.01%

Quick Ratio	2.64
Quick Ratio Avg TTM	2.01
Quick Ratio Avg 3Y	1.62
Current VS TTM Avg	+31.51%
Current VS 3Y Avg	+63.44%
Current VS 5Y Avg	+64.58%

ROIC	18.26%
ROIC Avg 3Y	17.84%
ROIC Avg 5Y	7.45%
Current VS 3Y Avg	+2.32%
Current VS 5Y Avg	+144.94%
Current VS 10Y Avg	+224.68%

ROA	13.86%
ROA Avg TTM	3.18%
ROA Avg 3Y	3.11%
Current VS TTM Avg	+336.47%
Current VS 3Y Avg	+345.79%
Current VS 5Y Avg	+568.43%

ROE	19.28%
ROE Avg TTM	28.10%
ROE Avg 3Y	28.61%
Current VS TTM Avg	-31.38%
Current VS 3Y Avg	-32.62%
Current VS 5Y Avg	-22.56%

Net Profit Margin	11.55%
Net Profit Margin Avg TTM	10.27%
Net Profit Margin Avg 3Y	9.72%
Current VS TTM Avg	+12.51%
Current VS 3Y Avg	+18.89%
Current VS 5Y Avg	+83.11%

Gross Profit Margin	74.83%
Gross Pft Margin Avg TTM	75.64%
Gross Pft Margin Avg 3Y	76.98%
Current VS TTM Avg	-1.07%
Current VS 3Y Avg	-2.79%
Current VS 5Y Avg	-2.56%

Tax Rate	0.68%
Tax Rate Avg 3Y	(0.01%)
Tax Rate Avg 5Y	4.65%
Current VS 3Y Avg	+8754.60%
Current VS 5Y Avg	-85.38%
Current VS 10Y Avg	-82.80%